Veterinary and medical worlds to unite to discuss infectious diseases
Experts from veterinary and medical sectors are to come together to share their knowledge on infectious diseases in the first major conference of its kind.
The One Health conference will discuss issues such as infection control; antimicrobial resistance and the threats posed by emerging zoonotic diseases.
Speakers will include Professor Peter Borriello, chief executive of the Veterinary Medicines Directorate, and Professor Anthony Kessel, director of Public Health England.
One Health aims to forge greater collaboration between human and veterinary medicine.
The conference, which will take place in London in October is being organised jointly by the Bella Moss Foundation (BMF), a charity promoting prudent antimicrobial use and effective infection control in both human and veterinary medicine, and the Royal Society of Medicine, an independent educational body for doctors, dentists, scientists and others involved in human health care.
Jill Moss, president of the Bella Moss Foundation, said: "WIth antimicrobial resistance and updated protocols hitting the headlines regularly, our speakers will discuss the key issues.
"For instance, what exactly is the current status of antimicrobial resistance? How is it affecting our lives?
"What are the veterinary, medical and research professions doing to resolve the challenges we face - and how can they persuade policy makers to take a united stand on the issue?"
Tom Keith-Welsh president of comparative medicine network, Royal Society of Medicine, said: "Antimicrobial resistance is a global issue requiring education, information and action.
"The conference programme will provide anyone with an interest in antimicrobial resistance a current and rounded perspective on this important and pressing issue."
Full details on the conference and how to register are available when www.onehealthbmf.com goes live on Friday.
The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.
